Business

Wall Street set to open higher as oil gains

Wall Street has been predicted to open higher today as oil held on to gains. – Reuters file pic, March 11, 2016. Wall Street has been predicted to open higher today as oil held on to gains. – Reuters file pic, March 11, 2016. Wall Street was set to open higher today as oil held on to gains, a day after the European Central Bank unveiled a widely expected stimulus package to spark growth in the region.

Markets initially gave a rousing reception to the ECB's program, which included expanding its asset-buying plan to 80 billion euros a month, but the mood turned sour after President Mario Draghi said further cut rates were unlikely.

Wall Street swung between gains and losses yesterdy and closed little changed as investors digested the mixed message.

"It looks like we're going to close the week on a high note as people are rethinking Draghi's powerful stimulus program," said Peter Cardillo, chief market economist at First Standard Financial in New York.

US crude rose more than 2%, after the International Energy Agency said oil prices might have bottomed as output in the United States and other non-OPEC countries was beginning to fall quickly.

At 8:23 am ET (9pm, Malaysian time), Dow e-minis were up 138 points, or 0.81%, with 17,858 contracts changing hands. S&P 500 e-minis were up 17.75 points, or 0.89%, with 198,167 contracts traded. Nasdaq 100 e-minis were up 45.75 points, or 1.07%, on 19,752 contracts.

The S&P 500 is down 2.% for the year, recovering from a steep selloff at the start of the year that was sparked by a rout in oil.

Investors' attention now turns to the US Federal Reserve, which is set to meet on March 15 to 16 to decide on monetary policy.

The Fed has said it is on track to raise rates gradually this year, but its decision will hinge on the health of the economy.

Recent data has shown the US labour market remains strong, but wage growth remains a concern.

Shares of Symantec were up 2.3% at US$17.70 premarket after RBC raised its rating on the stock to "outperform."

Alnylam Pharmaceuticals was up 2.4% at US$59.46 after JPMorgan upgraded the stock to overweight. – Reuters, March 11, 2016.

Comments

Please refrain from nicknames or comments of a racist, sexist, personal, vulgar or derogatory nature, or you may risk being blocked from commenting in our website. We encourage commenters to use their real names as their username. As comments are moderated, they may not appear immediately or even on the same day you posted them. We also reserve the right to delete off-topic comments